Abbisko Cayman Limited

Direct answer

Abbisko Cayman Limited is publicly traded on HKSE under the ticker 2256.HK.

Founded in 2016 and headquartered in Shanghai, People's Republic of China, Abbisko Cayman Limited operates as a clinical-stage biopharmaceutical company. Its core mission involves the discovery and advancement of small molecule oncology therapeutics. The company's development efforts primarily target small molecule precision oncology and immuno-oncology therapeutic areas. Among its prominent product candidates are...

Can you invest in Abbisko Cayman Limited?

Yes. Abbisko Cayman Limited is publicly traded on HKSE under the ticker 2256.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Abbisko Cayman Limited

Detailed equity research is provided by MarketSnap.